A pharmaceutical corporation is developing a research study to evaluate a novel blood test to screen for breast cancer. They enrolled 800 patients in the study, half of which have breast cancer. The remaining enrolled patients are age-matched controls who do not have the disease. Of those in the diseased arm, 330 are found positive for the test. Of the patients in the control arm, only 30 are found positive. What is this test’s sensitivity?
Q12
A scientist in Boston is studying a new blood test to detect Ab to the parainfluenza virus with increased sensitivity and specificity. So far, her best attempt at creating such an exam reached 82% sensitivity and 88% specificity. She is hoping to increase these numbers by at least 2 percent for each value. After several years of work, she believes that she has actually managed to reach a sensitivity and specificity even greater than what she had originally hoped for. She travels to South America to begin testing her newest blood test. She finds 2,000 patients who are willing to participate in her study. Of the 2,000 patients, 1,200 of them are known to be infected with the parainfluenza virus. The scientist tests these 1,200 patients’ blood and finds that only 120 of them tested negative with her new test. Of the following options, which describes the sensitivity of the test?
Q13
A 26-year-old medical student comes to the physician with a 3-week history of night sweats and myalgias. During this time, he has also had a 3.6-kg (8-lb) weight loss. He returned from a 6-month tropical medicine rotation in Cambodia 1 month ago. A chest x-ray (CXR) shows reticulonodular opacities suggestive of active tuberculosis (TB). The student is curious about his likelihood of having active TB. He reads a study that compares sputum testing results between 2,800 patients with likely active TB on a basis of history, clinical symptoms, and CXR pattern and 2,400 controls. The results are shown:
Sputum testing positive for TB Sputum testing negative for TB Total
Active TB likely on basis of history, clinical symptoms, and CXR pattern 700 2100 2,800
Active TB not likely on basis of history, clinical symptoms, and CXR pattern 300 2100 2,400
Total 1000 4200 5,200
Which of the following values reflects the probability that a patient with a diagnosis of active TB on the basis of history, clinical symptoms, and CXR pattern actually has active TB?
Q14
A 1-year-old boy is brought to the emergency room by his parents because of inconsolable crying and diarrhea for the past 6 hours. As the physician is concerned about acute appendicitis, she consults the literature base. She finds a paper with a table that summarizes data regarding the diagnostic accuracy of multiple clinical findings for appendicitis:
Clinical finding Sensitivity Specificity
Abdominal guarding (in children of all ages) 0.70 0.85
Anorexia (in children of all ages)
0.75 0.50
Abdominal rebound (in children ≥ 5 years of age) 0.85 0.65
Vomiting (in children of all ages) 0.40 0.63
Fever (in children from 1 month to 2 years of age) 0.80 0.80
Based on the table, the absence of which clinical finding would most accurately rule out appendicitis in this patient?
Q15
Health officials are considering making a change to the interpretation of the tuberculin skin test that will change the cut-off for a positive purified protein derivative (PPD) from 10 mm to 15 mm for healthcare workers. Which of the following can be expected as a result of this change?
Q16
A 17-year-old girl comes to the urgent care center after testing negative for HIV. She recently had sexual intercourse for the first time and had used a condom with her long-term boyfriend. She has no personal history of serious illness and no history of sexually transmitted infections. However, the patient is still worried about the possibility she has HIV despite the negative HIV test. She states that the package insert of the HIV test shows that of 100 patients who are found to be HIV-positive on PCR, 91 tested positive via the HIV test. Later in the day, a 23-year-old woman with a history of genitourinary chlamydia infection also comes to the urgent care center after testing negative for HIV. She states that she recently had unprotected intercourse with “someone who might have HIV.” If the test is conducted a second time on the 23-year-old patient, how will its performance compare to a second test conducted on the 17-year-old patient?
Q17
An at-home recreational drug screening test kit is currently being developed. They consult you for assistance with determining an ideal cut-off point for the level of the serum marker in the test kit. This cut-off point will determine what level of serum marker is associated with a positive or negative test, with serum marker levels greater than the cut-off point indicative of a positive test and vice-versa. The cut-off level is initially set at 4 mg/uL, which is associated with a sensitivity of 92% and a specificity of 97%. How will the sensitivity and specificity of the test change if the cut-off level is raised to 6 mg/uL?
Q18
A medical research study is beginning to evaluate the positive predictive value of a novel blood test for non-Hodgkin’s lymphoma. The diagnostic arm contains 700 patients with NHL, of which 400 tested positive for the novel blood test. In the control arm, 700 age-matched control patients are enrolled and 0 are found positive for the novel test. What is the PPV of this test?
Q19
A 16-year-old female is seen at her outpatient primary medical doctor's office complaining of a sore throat. Further history reveals that she has no cough and physical exam is notable for tonsillar exudates. Vitals in the office reveal HR 88, RR 16, and T 102.1. Using the Centor criteria for determining likelihood of Group A beta-hemolytic strep pharyngitis, the patient has a score of 3. A review of the primary literature yields the findings in Image A. What is the specificity of the Centor criteria using a score of 3 as a cutoff value?
Q20
A critical care fellow is interested in whether the auscultatory finding of pulmonary rales can accurately predict hypervolemic state. He conducts a study in 100 patients with volume overloaded state confirmed by a Swan Ganz catheter in his hospital's cardiac critical care unit. He also recruits 100 patients with euvolemic state confirmed by Swan Ganz catheter. He subsequently examines all patients in the unit for rales and finds that 80 patients in the hypervolemic group have rales in comparison to 50 patients in the euvolemic group. Which of the following is the positive predictive value of rales for the presence of hypervolemia?
Sensitivity/Specificity US Medical PG Practice Questions and MCQs
Question 11: A pharmaceutical corporation is developing a research study to evaluate a novel blood test to screen for breast cancer. They enrolled 800 patients in the study, half of which have breast cancer. The remaining enrolled patients are age-matched controls who do not have the disease. Of those in the diseased arm, 330 are found positive for the test. Of the patients in the control arm, only 30 are found positive. What is this test’s sensitivity?
A. 330 / (330 + 30)
B. 330 / (330 + 70) (Correct Answer)
C. 370 / (30 + 370)
D. 370 / (70 + 370)
E. 330 / (400 + 400)
Explanation: ***330 / (330 + 70)***
- **Sensitivity** measures the proportion of actual **positives** that are correctly identified as such.
- In this study, there are **400 diseased patients** (half of 800). Of these, 330 tested positive (true positives), meaning 70 tested negative (false negatives). So sensitivity is **330 / (330 + 70)**.
*330 / (330 + 30)*
- This calculation represents the **positive predictive value**, which is the probability that subjects with a positive screening test truly have the disease. It uses **true positives / (true positives + false positives)**.
- It does not correctly calculate **sensitivity**, which requires knowing the total number of diseased individuals.
*370 / (30 + 370)*
- This expression is attempting to calculate **specificity**, which is the proportion of actual negatives that are correctly identified. It would be **true negatives / (true negatives + false positives)**.
- However, the numbers used are incorrect for specificity in this context given the data provided.
*370 / (70 + 370)*
- This formula is an incorrect combination of values and does not represent any standard epidemiological measure like **sensitivity** or **specificity**.
- It is attempting to combine false negatives (70) and true negatives (370 from control arm) in a non-standard way.
*330 / (400 + 400)*
- This calculation attempts to divide true positives by the total study population (800 patients).
- This metric represents the **prevalence of true positives within the entire study cohort**, not the test's **sensitivity**.
Question 12: A scientist in Boston is studying a new blood test to detect Ab to the parainfluenza virus with increased sensitivity and specificity. So far, her best attempt at creating such an exam reached 82% sensitivity and 88% specificity. She is hoping to increase these numbers by at least 2 percent for each value. After several years of work, she believes that she has actually managed to reach a sensitivity and specificity even greater than what she had originally hoped for. She travels to South America to begin testing her newest blood test. She finds 2,000 patients who are willing to participate in her study. Of the 2,000 patients, 1,200 of them are known to be infected with the parainfluenza virus. The scientist tests these 1,200 patients’ blood and finds that only 120 of them tested negative with her new test. Of the following options, which describes the sensitivity of the test?
A. 82%
B. 86%
C. 98%
D. 90% (Correct Answer)
E. 84%
Explanation: ***90%***
- **Sensitivity** is calculated as the number of **true positives** divided by the total number of individuals with the disease (true positives + false negatives).
- In this scenario, there were 1200 infected patients (total diseased), and 120 of them tested negative (false negatives). Therefore, 1200 - 120 = 1080 patients tested positive (true positives). The sensitivity is 1080 / 1200 = 0.90, or **90%**.
*82%*
- This value was the **original sensitivity** of the test before the scientist improved it.
- The question states that the scientist believes she has achieved a sensitivity "even greater than what she had originally hoped for."
*86%*
- This value is not directly derivable from the given data for the new test's sensitivity.
- It might represent an intermediate calculation or an incorrect interpretation of the provided numbers.
*98%*
- This would imply only 24 false negatives out of 1200 true disease cases, which is not the case (120 false negatives).
- A sensitivity of 98% would be significantly higher than the calculated 90% and the initial stated values.
*84%*
- This value is not derived from the presented data regarding the new test's performance.
- It could be mistaken for an attempt to add 2% to the original 82% sensitivity, but the actual data from the new test should be used.
Question 13: A 26-year-old medical student comes to the physician with a 3-week history of night sweats and myalgias. During this time, he has also had a 3.6-kg (8-lb) weight loss. He returned from a 6-month tropical medicine rotation in Cambodia 1 month ago. A chest x-ray (CXR) shows reticulonodular opacities suggestive of active tuberculosis (TB). The student is curious about his likelihood of having active TB. He reads a study that compares sputum testing results between 2,800 patients with likely active TB on a basis of history, clinical symptoms, and CXR pattern and 2,400 controls. The results are shown:
Sputum testing positive for TB Sputum testing negative for TB Total
Active TB likely on basis of history, clinical symptoms, and CXR pattern 700 2100 2,800
Active TB not likely on basis of history, clinical symptoms, and CXR pattern 300 2100 2,400
Total 1000 4200 5,200
Which of the following values reflects the probability that a patient with a diagnosis of active TB on the basis of history, clinical symptoms, and CXR pattern actually has active TB?
A. 1.4
B. 0.50
C. 0.70
D. 0.88
E. 0.25 (Correct Answer)
Explanation: ***0.25***
- This value represents the **positive predictive value (PPV)** for active TB based on the initial clinical assessment criteria (history, symptoms, CXR).
- PPV is calculated as the number of true positives (700) divided by the total number of individuals with a positive clinical diagnosis (700 + 2100 = 2800). So, 700 / 2800 = 0.25.
- **This answers the question**: the probability that someone with a clinical diagnosis of active TB actually has the disease.
*Incorrect 1.4*
- This value is not a valid probability, as probabilities must be between 0 and 1.0.
- It might arise from an incorrect calculation or misinterpretation of the provided data.
*Incorrect 0.50*
- This value does not correspond to any standard diagnostic metric calculated from the provided data.
- The actual prevalence of TB (based on positive sputum) is 1000/5200 = 0.19, not 0.50.
- This is likely a distractor with no meaningful interpretation in this context.
*Incorrect 0.70*
- This value represents the **sensitivity** of the sputum test for detecting active TB.
- Sensitivity is calculated as true positives (700) divided by total with disease (700 + 300 = 1000). So, 700 / 1000 = 0.70.
- Sensitivity tells us how good the test is at detecting disease when present, not the probability of having disease given a positive clinical diagnosis.
*Incorrect 0.88*
- This value represents the **specificity** of the clinical assessment.
- Specificity is calculated as true negatives (2100) divided by total without disease (2100 + 300 = 2400). So, 2100 / 2400 = 0.875 ≈ 0.88.
- Specificity tells us how good the assessment is at ruling out disease in those without it, not the probability of disease given a positive assessment.
Question 14: A 1-year-old boy is brought to the emergency room by his parents because of inconsolable crying and diarrhea for the past 6 hours. As the physician is concerned about acute appendicitis, she consults the literature base. She finds a paper with a table that summarizes data regarding the diagnostic accuracy of multiple clinical findings for appendicitis:
Clinical finding Sensitivity Specificity
Abdominal guarding (in children of all ages) 0.70 0.85
Anorexia (in children of all ages)
0.75 0.50
Abdominal rebound (in children ≥ 5 years of age) 0.85 0.65
Vomiting (in children of all ages) 0.40 0.63
Fever (in children from 1 month to 2 years of age) 0.80 0.80
Based on the table, the absence of which clinical finding would most accurately rule out appendicitis in this patient?
A. Guarding
B. Vomiting
C. Anorexia
D. Fever (Correct Answer)
E. Rebound
Explanation: ***Fever***
- To **rule out** a diagnosis, a finding with **high sensitivity** is desired. A high sensitivity means that if the disease is present, the test result will almost always be positive. Therefore, a negative test result (absence of the finding) in a highly sensitive test makes the presence of the disease unlikely.
- Fever has a sensitivity of **0.80**, which means it is present in 80% of patients with appendicitis in the 1 month to 2 years age group. While 0.80 isn't extremely high, among the options applicable to this age group, it is the highest sensitivity for a "rule out" purpose. The absence of fever would therefore be the most useful finding to rule out appendicitis.
*Guarding*
- Guarding has a sensitivity of **0.70**, meaning it is present in 70% of appendicitis cases. While it's a useful sign, its sensitivity is lower than fever for ruling out the condition.
- Its higher specificity (0.85) means that its presence makes appendicitis more likely, but its absence is less helpful for ruling it out compared to a highly sensitive finding.
*Vomiting*
- Vomiting has a sensitivity of **0.40**, which is very low. This means that 60% of patients with appendicitis do not experience vomiting.
- Therefore, the absence of vomiting is not a reliable indicator to rule out appendicitis, as many appendicitis cases occur without it.
*Anorexia*
- Anorexia has a sensitivity of **0.75**. While higher than vomiting and guarding, it is still lower than fever (0.80) in the relevant age group for ruling out appendicitis.
- Its low specificity (0.50) indicates it's a common symptom even in children without appendicitis, making its presence less diagnostic and its absence less useful for ruling out.
*Rebound*
- The table states that abdominal rebound data is for children **≥ 5 years of age**. The patient is 1 year old.
- Therefore, this clinical finding's diagnostic accuracy is not applicable to the given patient's age and cannot be used for diagnosis or ruling out appendicitis.
Question 15: Health officials are considering making a change to the interpretation of the tuberculin skin test that will change the cut-off for a positive purified protein derivative (PPD) from 10 mm to 15 mm for healthcare workers. Which of the following can be expected as a result of this change?
A. Increase the sensitivity
B. Decrease the specificity
C. Decrease the sensitivity (Correct Answer)
D. No change to the sensitivity or specificity
E. Increase the precision
Explanation: ***Decrease the sensitivity***
- Increasing the PPD cut-off from 10 mm to 15 mm means fewer individuals will be identified as having a positive result. This will lead to more **false negatives**, thus **decreasing the sensitivity** of the test.
- A higher threshold implies that only stronger reactions are considered positive, potentially missing milder but true cases of tuberculosis infection.
*Increase the sensitivity*
- Increasing the cut-off would result in fewer positive tests, not more, thereby **reducing the test's ability to correctly identify** those with the disease.
- A higher threshold makes it harder to be classified as positive, which directly opposes an increase in sensitivity.
*Decrease the specificity*
- Increasing the cut-off criterion actually leads to an **increase in specificity**, as fewer healthy individuals would be misclassified as positive (**fewer false positives**).
- A higher threshold ensures that only those with a very strong reaction are considered positive, reducing the chance of incorrectly identifying someone without the disease.
*No change to the sensitivity or specificity*
- Any alteration to the cut-off value in diagnostic testing directly impacts the trade-off between **sensitivity and specificity**.
- Changing the diagnostic threshold inherently affects how well the test identifies true positives and true negatives.
*Increase the precision*
- **Precision** refers to the reproducibility of a measurement, meaning how close repeated measurements are to each other, not how many cases are correctly identified.
- Changing the cut-off value does not alter the inherent precision of how the PPD induration is measured.
Question 16: A 17-year-old girl comes to the urgent care center after testing negative for HIV. She recently had sexual intercourse for the first time and had used a condom with her long-term boyfriend. She has no personal history of serious illness and no history of sexually transmitted infections. However, the patient is still worried about the possibility she has HIV despite the negative HIV test. She states that the package insert of the HIV test shows that of 100 patients who are found to be HIV-positive on PCR, 91 tested positive via the HIV test. Later in the day, a 23-year-old woman with a history of genitourinary chlamydia infection also comes to the urgent care center after testing negative for HIV. She states that she recently had unprotected intercourse with “someone who might have HIV.” If the test is conducted a second time on the 23-year-old patient, how will its performance compare to a second test conducted on the 17-year-old patient?
A. Decreased positive predictive value
B. Increased validity
C. Increased sensitivity
D. Decreased negative predictive value (Correct Answer)
E. Increased specificity
Explanation: ***Decreased negative predictive value***
- The 23-year-old patient has a higher **pre-test probability** of HIV due to unprotected intercourse with a high-risk partner and a history of STIs, which increases the likelihood of HIV exposure and acquisition.
- A higher pre-test probability for a disease will **decrease the negative predictive value** of a test while increasing its positive predictive value, even if the test's sensitivity and specificity remain constant.
*Decreased positive predictive value*
- A higher **pre-test probability** (like in the 23-year-old patient) actually **increases the positive predictive value** of a diagnostic test, given the same sensitivity and specificity.
- The positive predictive value reflects the probability that a positive test result correctly identifies someone with the disease.
*Increased validity*
- **Validity** refers to how well a test measures what it is supposed to measure (accuracy), and it is not expected to change based on the individual patient's risk factors.
- The intrinsic properties of the test (sensitivity and specificity) determine its validity, not the prevalence of the disease or the patient's pre-test probability.
*Increased sensitivity*
- **Sensitivity** is a fixed characteristic of the test itself, defined as the proportion of true positives correctly identified by the test.
- A patient's individual risk factors or pre-test probability do not alter the inherent sensitivity of the HIV test.
*Increased specificity*
- **Specificity** is also a fixed characteristic of the test, representing the proportion of true negatives correctly identified.
- The test's specificity does not change based on the prevalence of HIV in the population or the patient's individual risk for the disease.
Question 17: An at-home recreational drug screening test kit is currently being developed. They consult you for assistance with determining an ideal cut-off point for the level of the serum marker in the test kit. This cut-off point will determine what level of serum marker is associated with a positive or negative test, with serum marker levels greater than the cut-off point indicative of a positive test and vice-versa. The cut-off level is initially set at 4 mg/uL, which is associated with a sensitivity of 92% and a specificity of 97%. How will the sensitivity and specificity of the test change if the cut-off level is raised to 6 mg/uL?
A. Sensitivity decreases, specificity decreases
B. Sensitivity decreases, specificity may increase or decrease
C. Sensitivity decreases, specificity increases (Correct Answer)
D. Sensitivity increases, specificity increases
E. Sensitivity increases, specificity decreases
Explanation: ***Sensitivity decreases, specificity increases***
- Raising the cut-off level means that the test will now require a **higher concentration of the serum marker** to be considered positive. This makes it harder for true positives to be identified (more false negatives), thus **decreasing sensitivity**.
- Conversely, a higher cut-off makes it less likely for healthy individuals (true negatives) to mistakenly test positive (fewer false positives), leading to an **increase in specificity**.
*Sensitivity decreases, specificity decreases*
- This option is incorrect because **raising the cut-off point** typically has opposing effects on sensitivity and specificity, not a decrease in both.
- A decrease in both would suggest a poorly designed or random change, which is not the expected outcome of systematically adjusting a threshold.
*Sensitivity decreases, specificity may increase or decrease*
- While it's true that real-world scenarios can be complex, for a single, direct change to a cut-off point, the relationship between sensitivity and specificity is generally inverse for a given test.
- The uncertainty implied by "may increase or decrease" does not fully capture the predictable inverse relationship that occurs when adjusting a diagnostic threshold.
*Sensitivity increases, specificity increases*
- **Increasing sensitivity** and **increasing specificity** simultaneously is only achievable by improving the diagnostic test itself (e.g., using a better marker), not by simply adjusting a fixed cut-off point.
- Adjusting a cut-off almost always involves a **trade-off** between these two metrics.
*Sensitivity increases, specificity decreases*
- This would occur if the cut-off level were **lowered**, not raised.
- A lower cut-off would detect more true positives (increased sensitivity) but would also incorrectly classify more healthy individuals as positive (decreased specificity).
Question 18: A medical research study is beginning to evaluate the positive predictive value of a novel blood test for non-Hodgkin’s lymphoma. The diagnostic arm contains 700 patients with NHL, of which 400 tested positive for the novel blood test. In the control arm, 700 age-matched control patients are enrolled and 0 are found positive for the novel test. What is the PPV of this test?
A. 400 / (400 + 0) (Correct Answer)
B. 700 / (700 + 300)
C. 400 / (400 + 300)
D. 700 / (700 + 0)
E. 700 / (400 + 400)
Explanation: ***400 / (400 + 0) = 1.0 or 100%***
- The **positive predictive value (PPV)** is calculated as **True Positives / (True Positives + False Positives)**.
- In this scenario, **True Positives (TP)** are the 400 patients with NHL who tested positive, and **False Positives (FP)** are 0, as no control patients tested positive.
- This gives a PPV of 400/400 = **1.0 or 100%**, indicating that all patients who tested positive actually had the disease.
*700 / (700 + 300)*
- This calculation does not align with the formula for PPV based on the given data.
- The denominator `(700+300)` suggests an incorrect combination of various patient groups.
*400 / (400 + 300)*
- The denominator `(400+300)` incorrectly includes 300, which is the number of **False Negatives** (patients with NHL who tested negative), not False Positives.
- PPV focuses on the proportion of true positives among all positive tests, not all diseased individuals.
*700 / (700 + 0)*
- This calculation incorrectly uses the total number of patients with NHL (700) as the numerator, rather than the number of positive test results in that group.
- The numerator should be the **True Positives** (400), not the total number of diseased individuals.
*700 / (400 + 400)*
- This calculation uses incorrect values for both the numerator and denominator, not corresponding to the PPV formula.
- The numerator 700 represents the total number of patients with the disease, not those who tested positive, and the denominator incorrectly sums up values that don't represent the proper PPV calculation.
Question 19: A 16-year-old female is seen at her outpatient primary medical doctor's office complaining of a sore throat. Further history reveals that she has no cough and physical exam is notable for tonsillar exudates. Vitals in the office reveal HR 88, RR 16, and T 102.1. Using the Centor criteria for determining likelihood of Group A beta-hemolytic strep pharyngitis, the patient has a score of 3. A review of the primary literature yields the findings in Image A. What is the specificity of the Centor criteria using a score of 3 as a cutoff value?
A. 41/46 = 89%
B. Not enough information has been provided
C. 45/50 = 90%
D. 41/50 = 82% (Correct Answer)
E. 9/54 = 17%
Explanation: ***41/50 = 82%***
- Specificity = **True Negatives / (True Negatives + False Positives)**
- With a Centor score cutoff of ≥3 as "positive" for GABHS pharyngitis, those without disease who score <3 are **true negatives (TN = 41)**
- Those without disease who score ≥3 are **false positives (FP = 9)**
- Therefore: Specificity = 41 / (41 + 9) = **41/50 = 82%**
*41/46 = 89%*
- This represents **Negative Predictive Value (NPV)**, not specificity
- NPV = TN / (TN + FN) = 41 / (41 + 5) = 41/46 = 89%
- NPV reflects the probability that a patient with a negative test (Centor score <3) truly lacks GABHS disease
- While clinically useful, this is not what the question asks for
*Not enough information has been provided*
- Incorrect: the referenced data table provides all necessary values
- **True negatives = 41** and **false positives = 9** allow direct calculation of specificity
- No additional information is required
*45/50 = 90%*
- This represents **Sensitivity**, not specificity
- Sensitivity = TP / (TP + FN) = 45 / (45 + 5) = **45/50 = 90%**
- Sensitivity reflects the proportion of true disease-positive patients who score ≥3 on the Centor criteria
- This is a different diagnostic parameter from specificity
*9/54 = 17%*
- This calculation uses an incorrect denominator (54 = TP + FP = 45 + 9)
- 9/50 = 18% would represent the **false positive rate (1 − specificity)**
- 9/54 = FP/(TP + FP), which is the **false discovery rate (1 − PPV)**, not specificity
- Does not correspond to specificity or any standard diagnostic parameter with the denominator shown
Question 20: A critical care fellow is interested in whether the auscultatory finding of pulmonary rales can accurately predict hypervolemic state. He conducts a study in 100 patients with volume overloaded state confirmed by a Swan Ganz catheter in his hospital's cardiac critical care unit. He also recruits 100 patients with euvolemic state confirmed by Swan Ganz catheter. He subsequently examines all patients in the unit for rales and finds that 80 patients in the hypervolemic group have rales in comparison to 50 patients in the euvolemic group. Which of the following is the positive predictive value of rales for the presence of hypervolemia?
A. 50/100
B. 80/100
C. 50/70
D. 80/130 (Correct Answer)
E. 100/200
Explanation: ***80/130***
- The **positive predictive value (PPV)** is the probability that a patient who tests positive for a disease (rales) actually has the disease (hypervolemia). It is calculated as **True Positives / (True Positives + False Positives)**.
- In this study, 80 hypervolemic patients had rales (True Positives), and 50 euvolemic patients had rales (False Positives). Therefore, PPV = 80 / (80 + 50) = 80/130.
*50/100*
- This fraction represents the **false positive rate** for rales in this study (50 euvolemic patients with rales out of 100 euvolemic patients).
- It does not account for the true positives or the overall positive test results, making it an incorrect calculation for PPV.
*80/100*
- This fraction represents the **sensitivity** of rales for hypervolemia (80 hypervolemic patients with rales out of 100 hypervolemic patients).
- Sensitivity measures the proportion of actual positives that are correctly identified, not the positive predictive value.
*50/70*
- This fraction represents the **negative predictive value (NPV)**, which is the probability that a patient without rales (negative test) truly does not have hypervolemia.
- NPV = True Negatives / (True Negatives + False Negatives) = 50 / (50 + 20) = 50/70, where 50 euvolemic patients lack rales and 20 hypervolemic patients lack rales.
- While this is a valid epidemiological measure, the question specifically asks for PPV, not NPV.
*100/200*
- This represents the **overall prevalence of hypervolemia** in the entire study population (100 hypervolemic patients out of 200 total patients).
- It does not consider the presence or absence of rales and is unrelated to the positive predictive value of rales.